Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 223 to 272 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
223\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 4. [source:swissprot;acc:q9uia0]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.24361\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
224\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 3 (arf nucleotide-binding site opener 3) (arno3 protein) (general receptor of phosphoinositides 1) (grp1). [source:swissprot;acc:o43739]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
225\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, cardiac muscle alpha isoform (myhc-alpha). [source:swissprot;acc:p13533]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
9035\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7279.6\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.24114\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
226\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, fetal (myosin heavy chain iib) (myhc-iib). [source:swissprot;acc:q9y623]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
227\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, perinatal (myhc-perinatal). [source:swissprot;acc:p13535]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
228\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, adult 2 (myosin heavy chain iia) (myhc-iia). [source:swissprot;acc:q9ukx2]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
229\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, fast skeletal muscle, embryonic (muscle embryonic myosin heavy chain) (smhce). [source:swissprot;acc:p11055]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
230\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, adult 1 (myosin heavy chain iix/d) (myhc-iix/d). [source:swissprot;acc:p12882]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
231\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, cardiac muscle beta isoform (myhc-beta). [source:swissprot;acc:p12883]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
232\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj756n5.1.1 (continues in em:al133324 as dj1161h23.3) (fragment). [source:sptrembl;acc:q9h430]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
233\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, extraocular (myhc-eo). [source:swissprot;acc:q9ukx3]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
234\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s6 kinase, 52kda, polypeptide 1; ribosomal protein s6 kinase, 52kd, polypeptide 1. [source:refseq;acc:nm\_012424]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5181.2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6410.58\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.23728\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
235\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s6 kinase-like 1. [source:refseq;acc:nm\_031464]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
236\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
spliceosomal u5 snrnp-specific 15 kda protein (dim1 protein homolog) (thioredoxin-like u5 snrnp protein u5-15kd). [source:swissprot;acc:o14834]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4723.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5828.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.23392\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
237\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm5. [source:swissprot;acc:q9y4y9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4567.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5631.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.23301\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
238\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 7; sds22. [source:refseq;acc:nm\_002712]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
27642.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
22440.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.23182\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
239\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase b precursor. [source:refseq;acc:nm\_020361]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7711.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6265.8\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.23071\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
240\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mast cell carboxypeptidase a precursor (ec 3.4.17.1) (mc-cpa) (carboxypeptidase a3). [source:swissprot;acc:p15088]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7711.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6265.79\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
241\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
plasma carboxypeptidase b2 isoform a preproprotein; carboxypeptidase u; thrombin-activatable fibrinolysis inhibitor; carboxypeptidase b-like protein; thrombin-activable fibrinolysis inhibitor. [source:refseq;acc:nm\_001872]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7711.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6265.76\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
242\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
max protein. [source:swissprot;acc:p25912]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4640.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5704.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22943\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
243\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 2; homer homolog 3 (drosophila). [source:refseq;acc:nm\_004839]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4246.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5208.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22652\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
244\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquinone biosynthesis protein coq7 homolog (coenzyme q biosynthesis protein 7 homolog) (timing protein clk-1 homolog). [source:swissprot;acc:q99807]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4250.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5211.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22614\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
245\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 1b. [source:refseq;acc:nm\_004272]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4251.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5212.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22595\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
246\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 3. [source:refseq;acc:nm\_004838]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4252.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5213.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22583\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
247\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein (wasp). [source:swissprot;acc:p42768]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6416.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7865.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22574\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
248\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene c-crk (p38) (adapter molecule crk). [source:swissprot;acc:p46108]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}}\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
249\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine-protein kinase abl2 (ec 2.7.1.112) (tyrosine kinase arg). [source:swissprot;acc:p42684]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7859.59\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
250\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase src (ec 2.7.1.112) (p60-src) (c-src). [source:swissprot;acc:p12931]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
251\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine-protein kinase hck (ec 2.7.1.112) (p59-hck/p60-hck) (hemopoietic cell kinase). [source:swissprot;acc:p08631]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
252\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
crk-like protein. [source:swissprot;acc:p46109]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
253\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase abl1 (ec 2.7.1.112) (p150) (c-abl). [source:swissprot;acc:p00519]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7859.59\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
254\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fyn (ec 2.7.1.112) (p59-fyn) (syn) (slk). [source:swissprot;acc:p06241]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
255\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fgr (ec 2.7.1.112) (p55-fgr) (c-fgr). [source:swissprot;acc:p09769]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
256\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
grb2-related adaptor protein 2 (gads protein) (growth factor receptor binding protein) (grblg) (grf40 adaptor protein) (grf-40) (grb-2-like protein) (grb2l) (grbx) (p38) (hematopoietic cell-associated adaptor protein grpl) (adapter protein grid) (sh3-sh2-sh3 adaptor mona). [source:swissprot;acc:o75791]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6417.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7859.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22476\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
257\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat displacement protein (cdp) (cut-like 1). [source:swissprot;acc:p39880]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6417.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7858.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22452\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
258\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein cux-2 (cut-like 2) (fragment). [source:swissprot;acc:o14529]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6417.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7857.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22449\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
259\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neural wiskott-aldrich syndrome protein (n-wasp). [source:swissprot;acc:o00401]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6417.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7852.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22355\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
260\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
signal recognition particle 9 kda protein (srp9). [source:swissprot;acc:p49458]\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
4244.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5193.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22343\vspace{3pt}}\\\cline{1-1}\cline{3-5}
\parbox{\wcA}{\vspace{3pt}\noindent
261\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
4247.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5192.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22255\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
262\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specific factor 4, 30kd subunit; cleavage-polyadenylation specificity factor, 30kd; no arches-like (zebrafish) zinc finger protein; cleavage-polyadenylation specificity factor. [source:refseq;acc:nm\_006693]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
24896.4\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
20431.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.21852\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
263\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
trs85 homolog. [source:swissprot;acc:q9y2l5]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
264\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cop9 constitutive photomorphogenic homolog subunit 3; cop9 complex subunit 3; jab1-containing signalosome subunit 3. [source:refseq;acc:nm\_003653]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4987.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4094.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.2181\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
265\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wd-repeat protein wdc146. [source:swissprot;acc:q9c0j8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
24806.9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
20369.9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.21782\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
266\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 160 kda subunit (cpsf 160 kda subunit). [source:swissprot;acc:q10570]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
267\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator (ralgef) (ralgds). [source:swissprot;acc:q12967]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
14021.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11523\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.21682\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
268\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 100 kda subunit (cpsf 100 kda subunit) (fragment). [source:swissprot;acc:q9p2i0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
24473.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
20127.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.21593\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
269\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm8. [source:swissprot;acc:o95777]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4590.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5575.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.21466\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
270\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fip1-like 1; rearranged in hypereosinophilia. [source:refseq;acc:nm\_030917]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
23640.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
19479.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.21358\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
271\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromatin accessibility complex protein 1 (chrac-1) (chrac-15) (huchrac15) (dna polymerase epsilon subunit p15). [source:swissprot;acc:q9nrg0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2554.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3093.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.21092\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
272\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone acetyltransferase type b catalytic subunit (ec 2.3.1.48). [source:swissprot;acc:o14929]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3858.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4669.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.21012\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/